Cargando…
Inhibition of the reward system by antipsychotic treatment
The mesolimbic dopaminergic reward system is responsible for the negative affective symptomatology of schizophrenia, which may be related to a low dopamine tonus within the ventral striatum. The monetary incentive delay (MID) task can be used to study the response of the ventral striatum to incentiv...
Autor principal: | Juckel, Georg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Les Laboratoires Servier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826766/ https://www.ncbi.nlm.nih.gov/pubmed/27069385 |
Ejemplares similares
-
Treatment mechanisms: traditional and new antipsychotic drugs
por: Tamminga, Carol A.
Publicado: (2000) -
Pharmacogenetics and outcome with antipsychotic drugs
por: Pouget, Jennie G., et al.
Publicado: (2014) -
Pharmacogenetics of antipsychotic-induced side effects
por: Lencz, Todd, et al.
Publicado: (2009) -
Developments in antipsychotic therapy with regard to hypotheses for schizophrenia
por: Ackenheil, Manfred, et al.
Publicado: (2002) -
DNA methylation and demethylation as targets for antipsychotic therapy
por: Guidotti, Alessandro, et al.
Publicado: (2014)